血浆miRNA特征谱用于有症状患者肺结核诊断
本研究在七个临床中心收集879例血浆样本,对264个血浆miRNA进行定量分析,在训练队列(n=410)中筛选出9个判别性miRNA并构建集成模型,在外部测试队列(n=469)中验证。模型区分结核与非结核的AUC在训练队列为0.84(95%CI 0.80-0.88),外部测试队列为0.86(95%CI 0.82-0.90),对涂片阴性确诊结核的AUC超过0.83,灵敏度和特异度均为0.75。
要点
- 九种血浆miRNA集成模型可区分结核与非结核,外部测试AUC为0.86。
- 对涂片阴性确诊结核患者,模型AUC超过0.83,灵敏度和特异度均为0.75。
- 该模型有望作为有症状患者结核诊断的分诊工具,但临床适用性需进一步研究。
核心结论
- 基于血浆九种miRNA表达特征谱的集成模型在诊断结核及区分其他常见肺部疾病方面显示出良好能力,但需进一步研究评估其临床适用性。
研究设计与样本
- 多中心研究,在七个临床中心收集879例血浆样本,包括健康个体和具有结核样症状和/或影像学特征的患者。
- 样本根据后续诊断评估分为结核、肺炎、肺癌和健康对照亚组。
- 对264个血浆miRNA在训练队列(n=410)和独立外部测试队列(n=469)中进行定量分析。
- 经降维和特征选择分析,识别出9个判别性miRNA,使用scikit-learn库在训练队列中训练集成模型,并在外部测试队列中评估。
主要发现
- 集成模型区分结核与非结核患者的AUC在训练队列为0.84(95%CI 0.80-0.88),外部测试队列为0.86(95%CI 0.82-0.90)。
- 对实验室确诊结核亚组,AUC为0.89(95%CI 0.85-0.93);对临床诊断但未确诊结核亚组,AUC为0.83(95%CI 0.79-0.88)。
- 在涂片阴性确诊结核患者中,AUC超过0.83,灵敏度和特异度均为0.75。
临床怎么用
- 该miRNA集成模型有望作为有症状患者结核诊断的分诊测试,辅助区分结核与其他常见肺部疾病。
- 在涂片阴性确诊结核患者中模型表现出较好判别能力,但临床适用性仍需进一步研究评估。
局限性
- 需进一步研究评估该模型的临床适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prompt and precise diagnosis of active pulmonary tuberculosis (TB) is crucial for controlling this disease and yet it remains a global challenge. The objective of this study was to identify a set of microRNAs (miRNAs) whose expression in plasma could be used as a triage test for diagnosing TB. METHODS: A total of 879 plasma samples were collected in seven clinical centres from healthy individuals and patients displaying TB-like symptoms and/or radiological features consistent with TB. The samples were classified as TB, pneumonia, lung cancer and HC subgroups based on subsequent diagnostic assessments.We performed quantitative profiling of 264 plasma miRNAs in a training cohort (n=410) and an independent external test cohort (n=469). After dimensionality reduction and feature selection analysis, we identified nine discriminative miRNAs and used them to train an ensemble model in a training cohort using the scikit-learn library, which was subsequently evaluated in the external test cohort. RESULTS: The ensemble model showed notable accuracy in discriminating TB from non-TB patients, yielding areas under the curve (AUC) of 0.84 (95% CI 0.80 to 0.88) for the training cohort and 0.86 (95% CI 0.82 to 0.90) for the external test cohort. When tested against subgroups of laboratory confirmed and clinically diagnosed but unconfirmed TB, the AUC values were 0.89 (95% CI 0.85 to 0.93) and 0.83 (95% CI 0.79 to 0.88), respectively. In smear-negative confirmed TB patients, the AUC exceeded 0.83, with a sensitivity and specificity of 0.75. CONCLUSIONS: Our miRNA ensemble model, based on detecting a nine-miRNA expression biosignature in plasma, demonstrated promising ability to diagnose TB and distinguish it from other common lung diseases but further studies are needed to assess its clinical applicability. TRIAL REGISTRATION NUMBER: ChiCTR2000039734.
引用
- Hu Y, Zhang H, Xu Y, et al. Plasma miRNA signature for the diagnosis of pulmonary tuberculosis in symptomatic patients. Thorax. 2026. PMID: 42350158. doi:10.1136/thorax-2024-222136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。